sentences.id: IEPA.d78.s187
sentences.origID: 240
sentences.text: To assess the possible involvement of PKC in AVP and IL-1 action in Leydig cells, the PKC inhibitor Calphostin C was tested
sentences.id: IEPA.d78.s187.e0
sentences.origID: 518
sentences.text: PKC
sentences.id: IEPA.d78.s187.e1
sentences.origID: 519
sentences.text: AVP
sentences.id: IEPA.d78.s187.e2
sentences.origID: 520
sentences.text: PKC
sentences.id: IEPA.d78.s187.i0
sentences.e1: IEPA.d78.s187.e0
sentences.e2: IEPA.d78.s187.e1
sentences.type: PPI
sentences.id: IEPA.d78.s188
sentences.origID: 241
sentences.text: These results confirm that AVP and PMA activate PKC and indicate that IL-1 likely does not activate PKC in Leydig cells
sentences.id: IEPA.d78.s188.e0
sentences.origID: 521
sentences.text: AVP
sentences.id: IEPA.d78.s188.e1
sentences.origID: 522
sentences.text: PKC
sentences.id: IEPA.d78.s188.e2
sentences.origID: 523
sentences.text: PKC
sentences.id: IEPA.d78.s188.i0
sentences.e1: IEPA.d78.s188.e0
sentences.e2: IEPA.d78.s188.e1
sentences.type: PPI